Drug Release
Drug Release of Bacterial Cellulose as Antibacterial Nano Wound Dressing
7
DESIGN AND CHARACTERIZATION OF VORICONAZOLE MICROSPHERESK. Rekha Rani*, R. Mohana Priya, G. Bhagya BuelaDOWNLOAD/VIEW/http://doi.org/10.5281/zenodo.164928
10
DESIGN, DEVELOPMENT AND EVALUATION OF CONTROLLED RELEASE OCULAR MINITABLETS OF FLUOROQUINOLONES
13
DEVELOPMENT AND IN-VITRO EVALUATION OF CARVEDILOL LOADED MUCOADHESIVE BUCCAL TABLET
5
PREPARATION, FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE ZOLMITRIPTAN TABLETS BY USING NATURAL POLYMERS
11
FORMULATION AND EVALUATION OF CONTROLLED RELEASE MUCOADHESIVE MATRIX TABLET OF NADOLOL
10
Controlled release tablet formulations of carvedilol
9
<p>Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy</p>
13
Formulation and evaluation of double walled microspheres of esomeprazole
13
QBD-BASED DEVELOPMENT AND EVALUATION OF TIME-DEPENDENT CHRONOPHARMACEUTICAL DRUG DELIVERY SYSTEM OF AMOXICILLIN TRIHYDRATE FOR MANAGEMENT OF BACTERIAL INFECTION
13
FORMULATION AND EVALUATION OF BACLOFEN CONTROLLED POROSITY OSMOTIC PUMP TABLETS
8
FORMULATION AND EVALUATION OF MICROSPHERES FOR IMMEDIATE AND SUSTAINED RELEASE OF DIFFERENT DRUGS USING SAME POLYMER
7
Design, Development and Characterization of Sustain Release Matrix Type Tablet of Cinnarazine Report
7
Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease
8
DESIGN AND EVALUATION OF ONCE DAILY LOSARTAN POTASSIUM SUSTAINED RELEASE MATRIX TABLET
7
V. Kiran Kumar Reddy*, A.M.S Sudhakar Babu, P.Venkateswararao, V. Venumadhuri
8
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MICROSPHERES OF ATORVASTATIN USING CHITOSAN AND ALGINATE
8
Design, development and evaluation of oral controlled drug delivery system (for Aceclofenac, an Anti-inflammatory drug).
226
Key words
10
FORMULATION, ASSESSMENT AND COMPATIBILITY ANALYSIS OF DIFFERENT POLYMERS LOADED MICROSPHERES BY NON AQUEOUS SOLVENT EVAPORATION TECHNIQUE: IN VITRO IN VIVO STUDY OF GLIBENCLAMIDE AS A MODEL DRUG
13